US 6482921
Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
expired A61KA61K38/00
Quick answer
US patent 6482921 (Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use) held by Essential Therapeutics, Inc. expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Essential Therapeutics, Inc.
- Grant date
- Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K38/00